Interpretation and Management of PSA Level of 7 ng/mL

Significance of PSA Level 7 ng/mL

A PSA of 7 ng/mL is considered elevated, as values above 4.0 ng/mL generally warrant further investigation according to the National Comprehensive Cancer Network 1
The likelihood of detecting prostate cancer on biopsy ranges from 17-32% for PSA levels between 4.0-10.0 ng/mL, where 7 ng/mL falls 1
PSA is not a cancer-specific marker, meaning many men with elevated PSA levels do not have prostate cancer 1
Other conditions that can cause PSA elevation include benign prostatic hyperplasia (BPH) 1
Recent instrumentation, trauma, or ejaculation can also cause PSA elevation 1

Perform a digital rectal examination (DRE) to assess for prostate abnormalities 1
Consider free/total PSA ratio testing for additional diagnostic information 1
Assess PSA velocity if prior values are available 1

A transrectal ultrasound-guided prostate biopsy is indicated with a persistent PSA of 7 ng/mL 1
Standard biopsy should include at least 8-12 cores targeting the peripheral zone 1

If prostate cancer is detected, a Gleason score of 7 would place the patient in the intermediate-risk category 2
Intermediate-risk patients (T2b-T2c, Gleason score 7, or PSA 10-20 ng/mL) have several treatment options depending on life expectancy 2
For life expectancy <10 years: observation, radiation therapy with or without ADT, or brachytherapy 2
For life expectancy ≥10 years: radical prostatectomy with lymph node dissection if risk of lymph node metastasis ≥2%, radiation therapy with or without ADT, or brachytherapy alone for favorable factors 2

Approximately 2 of 3 men with elevated PSA do not have prostate cancer 1
PSA testing should be interpreted in context with other clinical findings and risk factors 1